AI communications & PR intelligence for wellness.
EPR Wellness is the dedicated wellness title of the Everything-PR network — daily reporting, research, and AI-visibility analysis on how wellness brands and practitioners earn presence inside ChatGPT, Claude, Perplexity, Gemini, and Google AI Overviews.
Hemp PR is not wellness PR with cannabis vocabulary bolted on. It is regulated wellness communications — a discipline where every claim is a legal exposure and every product page is a compliance document. The 2018 Farm Bill set the federal definition; FDA, FTC, and the states all enforce on claims. Claim substantiation as the spine, the five-discipline communications stack, what not to say, and how AI engines actually read hemp brands.
The wellness industry outgrew the media infrastructure that once covered it. AI engines now fill the trust vacuum. Everything-PR's complete cluster on wellness communications and AI visibility in a $1.8 trillion category.
The supplement industry, a global giant exceeding $180 billion, faces a new challenge: Reddit. This article explores how Reddit communities fact-check product claims, scrutinize dosages, and demand transparency, forcing brands to adapt or lose credibility.
Functional medicine, offering concierge-level health services, has experienced a significant boom from 2020 to 2025. This growth is fueled by consumers willing to pay out-of-pocket for personalized health optimization not covered by traditional insurance, creating a billion-dollar industry with key players shaping its future.
The mental health PR landscape requires a unique approach due to its regulatory complexity, patient-safety implications, and the dynamics of celebrity disclosures. This article explores the strategies that work, and those that don't, for brands in this specialized category, offering insights into building sustained category position beyond traditional consumer marketing tactics.
Ozempic didn’t disrupt wellness. It exposed it. Between 2022 and 2025, a handful of medications fundamentally reshaped one of the world’s largest consumer categories. Novo Nordisk’s Ozempic (semaglutide), originally approved for diabetes treatment in 2017, became a cultural phenomenon through off-label weight-loss use before the launch of Wegovy, its FDA-approved weight-management counterpart. Eli Lilly followed with Mounjaro and later Zepbound, creating a competitive GLP-1 market that rapidly transformed consumer behavior. The impact extended far beyond pharmaceuticals.
Goop normalized the wellness founder. The category never recovered. What began as a curated lifestyle email evolved into something much larger: a beauty and wellness company, a media platform, a retail business, a Netflix series, a podcast network, and ultimately a blueprint for an entirely new kind of founder-driven brand. Today, nearly every major wellness personality operates some variation of the model Goop established.
